ai.doi.bio

Name

ai.doi.bio

Legal name

ai.doi.bio

Website

https://ai.doi.bio

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Molecular Visualization Software

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries) (HLAAAIAL)

akta.pro secondary industry

Protein Interaction & Structural Biology Platforms (cryo-EM, X-ray, NMR, biophysics) (HLAAAIAH)

Keywords

• Molecular visualization software
• Protein structure viewer
• 3D molecular rendering
• Structural biology tools
• WebGL protein viewer

Headquarters

HQ city

Victoria

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Unclear / no revenue signal detected: No pricing, ads, subscription, or commerce mechanisms are visible on the site; revenue model is not disclosed in the available source material.

Go-to-market motion1 record

Distribution channels1 record

Core offering

ai.doi.bio operates a single web-based, no-install 3D protein structure viewer built with Vite, React, TypeScript, and WebGL. Users can interactively explore four pre-loaded protein structures (TEM beta-lactamase 1erm, Ubiquitin 1ubq, Hemoglobin 4hhb, and Crambin 1crn) and load their own structure files directly in the browser, with controls for resetting zoom and orienting axes. The product is offered as a self-serve, globally accessible web application without signup or installation.

Differentiator

Problem solved

Functional benefit

Products and services

• ai.doi.bio Protein Structure Viewer

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature2 records

Scale indicators1 record

Direct peers

• Mol* (MolStar): Open-source, browser-based molecular visualization framework used across the structural biology community. Directly competes with ai.doi.bio on web-native 3D protein viewing and is the de facto standard for embedded PDB viewers.
• JSmol: JavaScript-only molecular viewer (the web port of Jmol) that displays 3D structures in the browser. Overlaps with ai.doi.bio's self-serve, no-install viewing proposition for the structural-biology community.
• NGL Viewer: WebGL-based molecular viewer originally developed at the Scripps Research Institute. Competes head-to-head with ai.doi.bio on browser-based interactive 3D protein structure rendering with no install required.
• iCn3D: NCBI's web-based 3D structure viewer that renders macromolecules directly in the browser from PDB IDs. Direct overlap with ai.doi.bio's core product, with the advantage of being backed by authoritative NCBI data.
• 3Dmol.js: JavaScript/WebGL library for molecular visualization developed at the University of Pittsburgh. Targets the same developer-and-researcher audience as ai.doi.bio for embedding interactive 3D structures in web pages.

Broad incumbents

• PyMOL: Widely used desktop molecular visualization system (open-source and commercial Schrödinger editions). Operates in the same structural-biology viewing market as ai.doi.bio, but as a heavyweight desktop incumbent rather than a web-native tool.
• RCSB Protein Data Bank: The authoritative repository for 3D macromolecular structure data, with a built-in 3D viewer. As the upstream data source for the PDB IDs used by ai.doi.bio (1erm, 1ubq, 4hhb, 1crn), it can add or deepen visualization features and squeeze out standalone viewers.
• BIOVIA Discovery Studio (Dassault Systèmes): Commercial life-sciences molecular modeling and visualization suite. Competes for the same structural-biology and drug-discovery viewers as ai.doi.bio, with a much broader commercial product portfolio.
• UCSF ChimeraX: Next-generation molecular visualization and analysis toolkit from UCSF. Targets the same structural-biology researcher segment as ai.doi.bio with a much broader feature set, though as a desktop application.

Emerging players

• AlphaFold (DeepMind / EMBL-EBI): AI-driven protein structure prediction database with its own integrated 3D viewer for predicted and experimental structures. Represents the AI-augmented future that ai.doi.bio's 'ai' branding gestures toward, and could absorb viewing use cases for predicted structures.

Market position

Customer concentration

• LinkedInlinkedin.com/company/doi-bio

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ai.doi.bio